OCULAR TECHNOLOGIES SARL
Ocular Technologies offers evaporators with proprietary monolayer coating for improving air conditioning performance.
OCULAR TECHNOLOGIES SARL
Industry:
Consumer Electronics Manufacturing
Founded:
2002-01-01
Status:
Active
Similar Organizations
Carrier Air Conditioning
Welcome to Carrier Air Conditioning, Australiaโs leaders in high technology heating, air conditioning and refrigeration solutions.
Termomontaza
Termomontaza is a manufacturer of home appliances such as heating systems, air conditioners and ventilation systems.
More informations about "Ocular Technologies Sarl"
Sun Pharma to Acquire Ocular Technologies
Ocular Technologies, Sarl (OTS), a portfolio company of Auven Therapeutics (Auven), an international private equity company focused on accelerated development of breakthrough โฆSee details»
Organization | Ocular Technologies SARL
Ocular Technologies SARL Report issue. For profit Phase 3. Founded: Epalinges Switzerland ... Organization Overview. First Clinical Trial. 2014 NCT02254265. First Marketed Drug. None ...See details»
Ocular Technologies Company Profile 2024: Valuation, โฆ
Ocular Technologies General Information Description. Developer of integrated ophthalmic telemedical devices designed to improve eye care and diagnosis. The company's product automates a traditional eye examination and sends a video โฆSee details»
Sun Pharma Completes Acquisition of Ocular Technologies Sarl
Dec 21, 2016 NEW DELHIโSun Pharmaceutical Industries announced that it has completed the acquisition of U.S.-based eyecare specialist Ocular Technologies Sarl, a portfolio company of โฆSee details»
Sun Pharma acquires Ocular Technologies Sarl - Crunchbase
Ocular Technologies Sarl Ocular Technologies Sarl offers evaporators with proprietary monolayer coating for improving air conditioning performance. Acquiring Organization: Sun Pharma Sun โฆSee details»
Ocular Technologies Sarl - Company Profile and News
Company profile page for Ocular Technologies Sarl including stock price, company news, executives, board members, and contact informationSee details»
Sun Pharma completes acquisition of Ocular Technologies Sarl
Dec 16, 2016 In October this year, Sun Pharma announced acquisition of 100 per cent equity stake in Ocular Technologies Sarl, owned by the private equity firm Auven Therapeutics, for a โฆSee details»
Sun Pharma acquires US-based Ocular Technologies Sarl
Oct 27, 2016 Sun Pharma acquires US-based Ocular Technologies Sarl. Press Trust of India 9890 Stories. Thursday October 27, 2016, 2 min Read.See details»
Auven Therapeutics Announces Sale of Ocular Technologies to โฆ
Oct 26, 2016 Sun Pharma will acquire 100 percent of Ocular Technologies Sarl, a wholly owned Auven subsidiary through which all Seciera rights are held, and thereby, the exclusive, โฆSee details»
Sun Pharma buys US-based Ocular Technologies for $ 40 million
Oct 27, 2016 Sun Pharma has acquired Ocular Technologies Sarl (OTS), a portfolio company of Auven Therapeutics (an international private equity company focused on accelerated โฆSee details»
Sun Pharma completes acquisition of Ocular Technologies Sarl
Dec 16, 2016 NEW DELHI: Sun Pharma today said it has completed the acquisition of the US-based eye care specialist Ocular Technologies Sarl. "All the necessary formalities for closure โฆSee details»
Auven Therapeutics announces sale of Ocular Technologies to Sun โฆ
Oct 26, 2016 * Auven Therapeutics-sale of 100 percent of Ocular Technologies Sarl to a wholly owned subsidiary of Sun Pharmaceutical Industries LtdSee details»
Auven Therapeutics Announces Closing of Sale of Ocular
Jan 6, 2017 Auven sold the exclusive, worldwide rights to Ocular Technologies Sarl, which owns the worldwide rights to Secieraโข (OTX-101), to a wholly owned subsidiary of Sun โฆSee details»
Sun Pharma completes acquisition of Ocular Technologies Sarl
Dec 16, 2016 In October this year, Sun Pharma announced acquisition of 100 per cent equity stake in Ocular Technologies Sarl, owned by the private equity firm Auven Therapeutics, for a โฆSee details»
Auven Therapeutics Announces Sale of Ocular Technologies to
Oct 26, 2016 Sun Pharma will acquire 100 percent of Ocular Technologies Sarl, a wholly owned Auven subsidiary through which all Seciera rights are held, and thereby, the exclusive, โฆSee details»
Ocular Technologies - Crunchbase Company Profile & Funding
Ocular Technologies develops an integrated ocular telemedicine solution to improve access to eye doctors. The company brings eye specialists closer to patients by allowing an automated, โฆSee details»
Ocular Technologies, a startup developing telemedical solutions to ...
Cambridge, MA, May 28, 2020โOcular Technologies, a startup that has developed a device-enabled telemedicine platform powered by machine learning to improve accessibility to eye โฆSee details»
Ocular Technologies, a startup developing telemedical solutions to ...
CAMBRIDGE, Mass., May 28, 2020 /PRNewswire/ -- Ocular Technologies, a startup that has developed a device-enabled telemedicine platform powered by machine learning to improve โฆSee details»